{"id":36671,"date":"2015-09-03T07:14:01","date_gmt":"2015-09-03T11:14:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36671"},"modified":"2015-09-03T07:14:01","modified_gmt":"2015-09-03T11:14:01","slug":"pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671","title":{"rendered":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR)"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Pharmacyte Biotech Inc (OTCMKTS:PMCB) <\/strong><a href=\"http:\/\/finance.yahoo.com\/news\/pharmacyte-biotech-executives-interviewed-role-130000452.html\">reported<\/a> that its COO Dr. Gerald W. Crabtree, Ph.D., and CEO, Mr. Kenneth L. Waggoner, JD have been featured in the September edition of PharmaVOICE Magazine.<\/p>\n<p style=\"text-align: justify;\">Waggoner, the CEO said that they are relying greatly on the advice of the three world known physicians in oncology in developing of upcoming clinical trial in people suffering with advanced pancreatic cancer and in an another study the management is in the planning process. Working collaboratively, the input of these three physicians has enable company to formulate a strategy to deal with an unmet medical need for this appalling disease and has facilitated company avoid drawbacks that otherwise might have recorded.<\/p>\n<p style=\"text-align: justify;\"><strong>Stellar Biotechnologies Inc (OTCMKTS:SBOTF) Updates On Reverse Stock Split Process<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Stellar Biotechnologies Inc (OTCMKTS:SBOTF) <\/strong><a href=\"http:\/\/finance.yahoo.com\/news\/stellar-biotechnologies-announces-reverse-stock-123000726.html\">disclosed<\/a> that as per the regulatory approval, they plan to complete the consolidation of company\u2019s issued and outstanding \u201cShares.\u201d They will opt for a 1-10 reverse stock split, the proposal of which was approved on August 26, 2015. Stellar Biotechnologies desires to list up on the NASDAQ Capital Market in coming period.<\/p>\n<p style=\"text-align: justify;\">The company has submitted an application to get its shares listed on NASDAQ and the quantitative guideline can be met only after the planned Reverse Stock Split.<\/p>\n<p style=\"text-align: justify;\"><strong>Biostem US Corp (OTCMKTS:HAIR) Halts Business Operations<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Biostem US Corp (OTCMKTS:HAIR) <\/strong><a href=\"http:\/\/www.marketwatch.com\/story\/biostem-us-corporation-suspends-operations-2013-07-17\">had<\/a> suspended of all of its business operations due to ongoing financial problems. The company terminated its employee, halted recruitment of medical partners, closed its website and stopped marketing initiatives.<\/p>\n<p style=\"text-align: justify;\">The company last reported its financial numbers in 2013 and since then has not filed any financial report with the U.S. SEC. As of May 2013, the assets were $3,636 while total liabilities stood at $917,298. Biostem still has to make payments to its professional advisors in lieu of their services.<\/p>\n<p style=\"text-align: justify;\">In last trading session, the stock price of Pharmacyte gained more than 1% to close the trading session at $0.0974.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its COO Dr. Gerald W. Crabtree, Ph.D., and CEO, Mr. Kenneth L. Waggoner, JD have been featured in the [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":32925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[11645,11644,11646,11643,11649,11642,11641,11648,11647],"stock_ticker":[],"class_list":["post-36671","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-biostem-us-corp","tag-biostem-us-corp-otcmktshair","tag-otcmktshair","tag-otcmktspmcb","tag-otcmktssbotf","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","tag-stellar-biotechnologies-inc","tag-stellar-biotechnologies-inc-otcmktssbotf","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its COO Dr. Gerald W. Crabtree, Ph.D., and CEO, Mr. Kenneth L. Waggoner, JD have been featured in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-03T11:14:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR)\",\"datePublished\":\"2015-09-03T11:14:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\"},\"wordCount\":328,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"keywords\":[\"Biostem US Corp\",\"Biostem US Corp (OTCMKTS:HAIR)\",\"OTCMKTS:HAIR\",\"OTCMKTS:PMCB\",\"OTCMKTS:SBOTF\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"Stellar Biotechnologies Inc\",\"Stellar Biotechnologies Inc (OTCMKTS:SBOTF)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\",\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"datePublished\":\"2015-09-03T11:14:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671","og_locale":"en_US","og_type":"article","og_title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR","og_description":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its COO Dr. Gerald W. Crabtree, Ph.D., and CEO, Mr. Kenneth L. Waggoner, JD have been featured in the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-03T11:14:01+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR)","datePublished":"2015-09-03T11:14:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671"},"wordCount":328,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","keywords":["Biostem US Corp","Biostem US Corp (OTCMKTS:HAIR)","OTCMKTS:HAIR","OTCMKTS:PMCB","OTCMKTS:SBOTF","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)","Stellar Biotechnologies Inc","Stellar Biotechnologies Inc (OTCMKTS:SBOTF)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671","name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","datePublished":"2015-09-03T11:14:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-ceo-features-in-pharmavoice-sbotf-hair-36671#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) CEO Features In \u2018PharmaVOICE\u2019 (SBOTF, HAIR)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36671"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36671\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/32925"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36671"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}